fda - Search News

FDA Approves 1st Non-Opioid Pain Drug in 20 Years

Hosted on MSN · 8m

FDA approves 1st new class of opioid-free painkillers in over 20 years

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

U.S. News & World Report · 1h

What to Know: FDA Approves Non-Opioid Pain Medication, Journavx

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in more than 20 years.

Bloomberg on MSN · 6h

New pain drug, Vertex’s Journavx, gets FDA approval as safer alternative to addictive opioids

Each year, about 125 million opioid prescriptions are written for Americans with pain caused by broken bones, burns, surgeries, and other injuries and procedures.

FDA, recall and Chocolate

YAHOO!News · 3h

Chocolate recall elevated to highest risk level by FDA due to risk of 'adverse health consequences’

A major chocolate recall has been upgraded to the highest possible risk level. Last month, Cal Yee Farm LCC issued a recall on its chocolate and yogurt covered products, since they may have contained undeclared substances,

This chocolate recall has been upgraded to FDA’s highest risk level

A December 2024 chocolate recall has been upgraded to highest risk level by the U.S. Food and Drug Administration (FDA), which says consuming the product could “cause serious adverse health consequences or death.

Chocolate Recall Updated to Highest Risk Level, FDA Warns Consumption Could Cause Death

Cal Yee Farms' dark chocolate walnuts, dark chocolate almonds and dark chocolate apricots have been given a Class 1 recall classification because the chocolates contained undeclared milk

Hosted on MSN1h

FDA approves 'ketamine' nasal spray for depression — here's everything you need to know

A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

The American Journal of Managed Care47m

FDA Approves First HER2-Ultralow Companion Diagnostic, Expanding Treatment Eligibility

Roche’s PATHWAY HER2 (4B5) test helps identify patients with HER2-ultralow breast cancer, who may be eligible for targeted ...

9hon MSN

What is Non-Opioid Pain Medication? Journavx Approved by FDA

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

9h

FDA Opens Up A New Path To The U.S. Market For This Under 30 Biotech Startup

More than 10 million babies have been born through IVF, yet the process is still invasive and costly. Plus, why a venture ...

3don MSN

FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

1d

Axsome Therapeutics announces FDA approval of Symbravo

Axsome Therapeutics (AXSM) announced that the U.S. FDA has approved Symbravo for the acute treatment of migraine with or without aura in ...

Hosted on MSN1d

Frito-Lay Recalls 6,000 Bags of Lay’s Potato Chips Due to Dairy Allergen Risk

Frito-Lay has recalled over 6,000 bags of Lay’s Classic Potato Chips due to undeclared milk, which poses a serious risk to ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results